Learning Tool Fills Knowledge Gap Pn Botulinum Toxin Type B For Cervical Dystonia
In recognition that physician comfort and knowledge with techniques around botulinum toxin injections lead to the best results for patients with cervical dystonia (CD), Solstice Neurosciences, Inc. (Solstice) has created MYOBLOC University, an online, self-study resource that incorporates new learning technology. The course integrates multi-dimensional, life-like animation throughout the content -- with anatomy based on real patients with CD and actual injection technique demonstrations with Myobloc (Botulinum Toxin Type B) Injectable Solution.
"MYOBLOC University is for busy physician specialists who want to expand the scope of treatment options for their patients with cervical dystonia, and for those seeking a comprehensive review of the condition and the role of botulinum toxin type B," said Eric J. Pappert, MD, assistant professor of neurology and director of the Parkinson's Disease and Movement Disorders Program at the University of Texas Health Science Center in San Antonio, Texas and Vice President, Medical & Scientific Affairs of Solstice. Dr. Pappert led the development of MYOBLOC University.
CD is often a disabling and painful movement disorder that requires life- long management. Also known as spasmodic torticollis, it is a condition that primarily affects the cervical area of the neck. While the exact cause of CD is unknown, scientists believe the problem originates in the basal ganglia area of the brain that is instrumental in movement. The treatment goal is to lessen symptoms of spasms, pain and impaired posture, and to improve functionality.
"A broad range of treatment options are often needed to address the symptoms of cervical dystonia. The botulinum toxins are considered the primary and most effective form of treatment, which makes it critically important for physicians to be experienced with both forms of botulinum toxin available here in the U.S.," noted Dr. Pappert.
The multi-media content covered in MYOBLOC University includes:
-- Detailed overview of the clinical presentation and diagnosis of CD -- with video depictions demonstrating abnormal movements and which muscle are involved
-- Review of currently available treatments -- oral medications, surgical options, injections with botulinum toxin, and complementary therapies
-- Fundamentals for dosing and muscle injection techniques when using MYOBLOC to reduce the severity of abnormal head position and neck pain associated with CD
-- Patient case studies that illustrate the challenges and potential solutions in managing CD patients
-- A post-test for participants to gauge their understanding of the materials presented
Upon completing the online lesson, physicians can request in-person training with MYOBLOC, which is available through Solstice in a variety of venues. The company's overall goal is to support physicians who care for CD patients -- ranging from neurologists to physiatrists to anesthesiologists and pain management physicians.
MYOBLOC University does not offer continuing medical education credits.
Myobloc (Botulinum Toxin Type B) Injectable Solution is indicated for the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.
Before administering MYOBLOC, physicians should consult the full Prescribing Information.
The most frequently reported adverse events with MYOBLOC are dry mouth, dysphagia, dyspepsia, and injection site pain. These adverse events are generally mild to moderate, transient, self-resolving, and more common with higher doses.